TriSalus Life Sciences, Inc. TLSI Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s common stock, shares issued (in shares)?
- TriSalus Life Sciences, Inc. (TLSI) reported common stock, shares issued (in shares) of $61.41M in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s common stock, shares issued (in shares) changed year-over-year?
- TriSalus Life Sciences, Inc.'s common stock, shares issued (in shares) increased by 90.3% year-over-year, from $32.27M to $61.41M.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s common stock, shares issued (in shares)?
- Over 3 years (2022 to 2025), TriSalus Life Sciences, Inc.'s common stock, shares issued (in shares) has grown at a 423.8% compound annual growth rate (CAGR), from $347.93K to $50M.